Hemodialysis Catheters Market Size & Share 2025 - 2034

Hemodialysis Catheters Market Size

The global hemodialysis catheters was valued at USD 990.9 million in 2024. The market is expected to grow from USD 1.1 billion in 2025 to USD 1.9 billion in 2034, at a CAGR of 6.6%, according to the latest report published by Global Market Insights Inc.

The global hemodialysis catheters market rises for the reason that chronic kidney disease (CKD) as well as end-stage renal disease (ESRD) prevail, thereby demanding dialysis services in a large way. More awareness of renal replacement therapies aids market growth. Across the globe, advancements in catheter technology are also helping the market grow.
 

Another major driver is that the geriatric population is growing because older individuals are in fact more prone to kidney-related complications that do require long-term hemodialysis. Additionally, increased healthcare spending, expanding access to dialysis centers, and the development of biocompatible and infection-resistant catheters are fueling market growth during the forecast period.
 

Hemodialysis catheters market witness steady growth, growing from USD 816.5 million in 2021 to USD 927.7 million in 2023, driven by the increasing global prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), which continue to be major public health challenges. Rising cases of diabetes and hypertension, the two leading causes of kidney failure, are further contributing to the demand for effective dialysis treatments. Hemodialysis catheters play a crucial role in providing vascular access for patients undergoing long-term or emergency dialysis, making them indispensable in clinical practice.
 

In addition, the growing geriatric population worldwide, which is more susceptible to kidney-related disorders, is expanding the patient pool and subsequently boosting the adoption of hemodialysis catheters. Technological advancements in catheter design, such as the introduction of tunneled catheters with improved biocompatibility, reduced infection risk, and enhanced blood flow efficiency, are also supporting market growth.
 

Furthermore, governments and healthcare organizations are actively investing in dialysis infrastructure to improve accessibility and affordability, especially in emerging economies, thereby creating new opportunities for manufacturers. Increasing healthcare expenditure, coupled with awareness programs regarding renal health and early diagnosis, is further encouraging patients to opt for hemodialysis treatments. Moreover, the rising number of dialysis centers and partnerships between healthcare providers and device manufacturers are enhancing treatment availability and driving product adoption.
 

Hemodialysis catheters are specialized medical devices inserted into large veins, typically in the neck, chest, or groin, to provide vascular access for patients requiring hemodialysis. They enable efficient removal and return of blood during treatment, serving as a temporary or long-term solution for managing kidney failure and related conditions.
 

Hemodialysis Catheters Market Trends

The rising prevalence of chronic kidney disorders (CKD) along with end-stage renal disease (ESRD) greatly drives the hemodialysis catheters industry, as these conditions frequently require dialysis treatments to sustain life.
 

• Globally, the burden from CKD is escalating due to diabetes, hypertension, obesity, and changing lifestyles. This mainly increases the demand for hemodialysis procedures. According to international health organizations, millions of patients progress to innovative kidney failure every year, requiring instant vascular access for dialysis, where catheters serve as a main solution, particularly in emergency and short-term cases.
   
• Moreover, the rising geriatric population, which is more vulnerable to kidney-related difficulties, further expands the patient number. From the macroeconomic front, improving healthcare structure in developing economies, clubbed with rising healthcare expenditure and government initiatives to expand dialysis facilities, is enabling wider access to treatment.
   
• Augmented investments in medical technology and calculated collaborations between healthcare workers and manufacturers are also fast-tracking product availability and innovation. Meanwhile, microeconomic factors such as the rising affordability of healthcare services, better insurance coverage, and patient awareness are supporting adoption rates.
   
• The shift towards urbanization and sedentary lifestyles has heightened the prevalence of risk factors like diabetes and hypertension, further fueling demand for hemodialysis catheters. Moreover, advancements in catheter design, focusing on minimizing infection risks and improving blood flow, are increasing physician preference and patient safety, reinforcing market growth.
   
• Together, the combination of rising disease prevalence, supportive healthcare policies, economic developments, and technological progress positions the market for sustained expansion in the coming years.
   

Hemodialysis Catheters Market Analysis

Based on catheter type, the market is bifurcated into short-term hemodialysis catheters, and long-term hemodialysis catheters. The short-term hemodialysis catheters segment accounted for 63.7% of the market in 2024 due to their critical role in it, they provide immediate vascular access for acute kidney injury and emergency dialysis cases. Segment growth is supported by the ease with which they are inserted and by how cost-effective they are. Typical use within hospital locales also increases section gain. The segment is expected to exceed USD 1.2 billion by 2034, growing at a CAGR of 6.5% during 2025 to 2034. On the other hand, long-term hemodialysis catheters segment is expected to grow with the fastest CAGR of 6.9% through 2034. Catheter materials advance as they reduce infection risk. This increases the adoption even further, also decreasing thrombosis for more sustained treatment needs.
 

• The short-term Hemodialysis catheters segment is driven by the critical role that they perform when they provide rapid vascular access for patients who require immediate dialysis, particularly when acute kidney injury (AKI) along with emergency situations occur. Because they are easy for insertion, cost effective, and can quickly initiate life-saving Hemodialysis procedures, hospitals and critical care settings widely use these catheters. AKI incidence increases often linked to sepsis cardiovascular complications and surgical interventions thus short-term catheters are used more often.
   
• Additionally, the growing number of hospital admissions and emergency cases globally has created consistent demand for these devices. Healthcare providers prefer short-term catheters as a first-line option for acute treatment before transitioning patients to long-term dialysis access methods, thereby reinforcing their utilization.
   
• As advancements improve catheter design to minimize infection and mechanical complications, the short-term segment continues to maintain a strong position in the hemodialysis catheters market.
   
• On the other hand, long-term hemodialysis catheters segment is expected to grow with the fastest CAGR during the analysis period. The long-term hemodialysis catheters segment is expected to grow with the fastest CAGR during the analysis period, driven by the increasing prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD) requiring prolonged dialysis support.
   
• As the number of patients dependent on long-term treatment rises, the demand for durable, biocompatible catheters offering reduced infection risks and improved blood flow efficiency continues to expand. Technological advancements in catheter design, combined with growing healthcare investments and improved patient management strategies, are further supporting this growth. Additionally, the aging population and increasing life expectancy contribute to sustained demand for long-term solutions.
   

Based on the product, the hemodialysis catheters market is segmented into tunneled catheters, and non-tunneled catheters. The tunneled catheters segment dominated the market in 2024 with a revenue of USD 737.8 million.
 

• The tunneled hemodialysis catheters segment due to their ability to provide reliable long-term vascular access for patients undergoing prolonged dialysis treatment. These catheters are designed with a subcutaneous tunnel that reduces infection risk and ensures better stability, making them highly preferred by healthcare providers. Their enhanced durability and improved patient comfort compared to non-tunneled catheters also contribute to higher adoption.
   
• Rising cases of chronic kidney disease (CKD) and end-stage renal disease (ESRD), which require extended dialysis support, are driving consistent demand for tunneled catheters. Furthermore, advancements in biocompatible materials, antimicrobial coatings, and innovative designs that minimize clotting and mechanical complications are fueling market growth.
   
• With increasing healthcare expenditure, a growing geriatric population, and greater emphasis on safe, long-term solutions, tunneled catheters continue to be the most widely used option in both developed and emerging healthcare systems, supporting their leading market share.
   
• On the other hand, the non-tunneled hemodialysis catheters segment also plays a vital role in the market, primarily driven by their use in emergency and short-term dialysis procedures. These catheters are often the first line of treatment for patients requiring immediate vascular access, especially in acute kidney injury (AKI) or sudden renal failure cases. Their ease of insertion, cost-effectiveness, and quick availability make them highly suitable for critical care settings and temporary dialysis management.
   
• Non-tunneled catheters are extensively used in hospitals and intensive care units, where patients may not yet have a permanent dialysis access option. Growth in the number of emergency dialysis cases and the rising global burden of renal complications are fueling demand for this segment. While infection risks remain a limitation, ongoing improvements in design and coating technologies are enhancing safety and outcomes.
   

Based on material, the hemodialysis catheters market is bifurcated into polyurethane, silicone. The polyurethane segment dominated the market in 2024 and grew with a CAGR of 6.8% till 2034.
 

• Polyurethane catheters are widely preferred since they balance strength and flexibility with durability excellently, which ensures reliable vascular access during dialysis sessions. They are able to withstand the high-pressure blood flow without any collapsing, and this makes them so suitable for longer-term use. They do also reduce complications in instances when they are used for treatment. Strong manufactured polyurethane catheters having thin walls allow better blood flow and dialysis. They are also biocompatible and offer smoother insertion, minimizing trauma to veins and patient discomfort.
   
• Their cost-effectiveness and also wide accessibility throughout health care settings power even further increasing adoption. Technological developments such as kink-resistant designs with antimicrobial coatings improve safety. They lessen chances of infection and chances of thrombosis. Polyurethane catheters are in fact still the most commonly chosen material when it comes to dialysis care with the rising of the prevalence across the globe of CKD and also ESRD.
   
• The second largest segment, silicone, held a market share of 11.6% in 2024. The silicone segment, though smaller, is observing notable growth in the hemodialysis catheters market due to its greater biocompatibility and softness, making it an ideal option for patients requiring long-term dialysis access.
   
• Silicone catheters are extremely flexible, reducing the risk of vein trauma and improving patient comfort, which is particularly important for elderly and chronic patients. Their inert, non-reactive nature minimizes irritation and immune response, lowering the chances of thrombosis and infection compared to other materials.
   

Based on tip configuration, the hemodialysis catheters market is segmented into step-tip catheters, split-tip catheters, symmetric catheters, and other tip configurations. The step-tip catheters segment was anticipated to be worth USD 404.5 million in 2024 and is expected to grow at 6.1% CAGR through 2034.
 

• The step-tip catheters segment witnesses more meaningful growth because of the proven efficacy that exists in hemodialysis procedures and its common clinical adoption. These catheters are designed in order to lower the risk that vessel wall trauma poses and also improve blood flow dynamics. These features ensure better patient outcomes. Chronic kidney disease like CKD and end-stage renal disease like ESRD increasingly prevail now, driving at this segment so greatly. Reliable as well as safe vascular access options are necessary on account of this.
   
• Step-tip catheters are preferred by healthcare professionals because they insert easily, remain stable, and limit recirculation incidence, increasing dialysis efficiency. Biocompatible material advancements further propel their demand, with innovations minimizing thrombosis and infection. Dialysis infrastructure investments are rising, as the patient pool is growing within, particularly among the elderly, which also contribute to segment expansion.
   
• The second largest segment, split-tip catheters, held a market share of 35.6% in 2024. The split-tip catheters segment is expected to grow steadily, driven by their unique design that provides superior blood flow and reduced recirculation compared to other configurations.
   
• These catheters allow simultaneous inflow and outflow of blood through separated lumens, which enhances dialysis efficiency and patient safety. The increasing demand for high-performance catheters among patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD) is a key driver for this segment.
   

Learn more about the key segments shaping this market

Download Free PDF

Based on lumen, hemodialysis catheters market is classified into single-lumen, double-lumen, triple-lumen. The single-lumen segment is expected to reach 466.2 million by 2034.
 

• The single-lumen hemodialysis catheters segment dominated the market in 2024, driven primarily by its simplicity, cost-effectiveness, and suitability for short-term or emergency dialysis procedures. These catheters are easy to insert, require minimal maintenance, and are ideal for acute care settings where rapid vascular access is needed. Their widespread adoption in hospitals and dialysis centers is further supported by growing incidences of chronic kidney disease (CKD) and end-stage renal disease (ESRD), which increase the demand for dialysis interventions.
   
• Additionally, single-lumen catheters are often preferred in resource-limited regions due to affordability and availability, making them a practical choice for healthcare providers. The segment also benefits from advancements in catheter materials that reduce infection and thrombosis risks, enhancing patient safety. Combined with expanding healthcare infrastructure and increasing awareness of renal health, these factors collectively drive the continued dominance of single-lumen catheters in the market.
   
• The double-lumen hemodialysis catheters segment is driven by the need for more efficient and continuous dialysis procedures. These catheters allow simultaneous blood removal and return, ensuring higher blood flow rates and improved dialysis efficacy compared to single-lumen devices. This makes them particularly suitable for patients requiring prolonged or repeated hemodialysis sessions, including those with chronic kidney disease (CKD) and end-stage renal disease (ESRD). Growing adoption in advanced healthcare facilities, where efficiency and patient safety are critical, supports segment growth.
   
• Technological improvements, such as anti-microbial coatings and biocompatible materials, reduce infection risks and enhance catheter longevity. Additionally, increasing healthcare expenditure, expanding dialysis centers, and a rising number of patients opting for long-term hemodialysis contribute to the rising demand for double-lumen catheters, positioning this segment as a key growth driver in the global market.
  
   

North America Hemodialysis Catheters Market
 

The North America dominated the global hemodialysis catheters industry with a market share of 46.9% in 2024.
 

• The North America market dominated worldwide in 2024, since the U.S. and Canada show a high prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD). Because diabetes as well as hypertension are rising in incidence as key risk factors for kidney failure, the demand for hemodialysis treatments has greatly increased by comparison. That advanced healthcare infrastructure can support market growth, and dialysis centers that are well-established do also support market growth. Furthermore, biocompatible and infection-resistant materials that are in revolutionary catheter technologies have become adopted quite widely for supporting market growth.
   
• Strong government initiatives and reimbursement policies, including Medicare and private insurance coverage for dialysis procedures, enhance patient access to treatment. Additionally, growing awareness of renal health, early diagnosis programs, and research investments by leading medical device manufacturers contribute to the region’s market leadership. The increasing geriatric population, who are more susceptible to kidney-related complications, further expands the patient pool, making North America a highly lucrative and steadily growing market for hemodialysis catheters.
   

The U.S. hemodialysis catheters market size reached USD 437.5 million in 2024, driven by the rising prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), fueled by increasing cases of diabetes, hypertension, and obesity. Growing awareness about kidney health and early diagnosis programs has resulted in a higher number of patients undergoing dialysis treatments, directly boosting catheter demand. The presence of advanced healthcare infrastructure, well-established dialysis centers, and high adoption of innovative catheter technologies, such as tunneled and biocompatible catheters, further supports market growth.
 

• Additionally, favorable reimbursement policies and increasing healthcare expenditure enhance accessibility and affordability for patients, driving adoption. The aging population, who are more susceptible to renal complications, adds to the growing patient base requiring both short-term and long-term dialysis solutions.
  
   

Europe Hemodialysis Catheters Market
 

Europe hemodialysis catheters accounted for USD 170.3 million in 2024 and is anticipated to show lucrative growth over the forecast period.
 

• The European market is expected to witness lucrative growth, driven by the rising prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD) across the region. Increasing cases of diabetes and hypertension, major risk factors for kidney failure, are contributing to higher demand for hemodialysis treatments. Well-established healthcare infrastructure, advanced medical facilities, and high healthcare expenditure support widespread adoption of innovative catheter technologies.
   
• The presence of leading market players and continuous product development, including biocompatible and infection-resistant catheters, further strengthens market growth. Additionally, supportive government initiatives and reimbursement policies in countries such as Germany, France, and the UK enhance accessibility and affordability of dialysis services.
   

Germany dominates the European hemodialysis catheters market, showcasing strong growth potential, due to its advanced healthcare infrastructure, well-established dialysis centers, and high-quality medical services. The country has a significant prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), driven by rising rates of diabetes, hypertension, and an aging population, which fuels demand for dialysis treatments.
 

• Strong government support, high healthcare expenditure, and reimbursement policies ensure widespread access to hemodialysis procedures, further boosting catheter adoption. Additionally, Germany is a hub for medical technology innovation, with manufacturers focusing on advanced, biocompatible, and infection-resistant catheters that enhance patient safety and treatment efficiency.
   
• The presence of key market players and research collaborations also facilitates rapid product availability and technological advancement.
  
   

Asia Pacific Hemodialysis Catheters Market
 

The Asia Pacific hemodialysis catheters is anticipated to grow at the highest CAGR of 9.1% during the analysis timeframe.
 

• The Asia Pacific market should grow fastest during this analysis since chronic kidney disease (CKD) and end-stage renal disease (ESRD) increase quickly across the region. Because of an aging population, the patient pool requiring hemodialysis is expanding greatly. Diabetes and hypertension, together with obesity are each rising in incidence, which further contributes to the expansion.
   
• Refining healthcare infrastructure, administration initiatives to enhance access to renal care, and growing investments in modern dialysis centers are further fueling market growth. Moreover, rising awareness about kidney health, early diagnosis, and progressive treatment options are encouraging patients to seek timely dialysis interventions.
   
• Technological progressions in catheter design, including biocompatible materials and infection-resistant features, are enhancing treatment outcomes and safety, supporting adoption.
   

China hemodialysis catheters market is estimated to grow with a significant CAGR, in the Asia Pacific hemodialysis catheters, driven by the rising prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD) among its large population. Rapid urbanization, changing lifestyles, and increasing incidences of diabetes and hypertension have contributed to the growing patient pool requiring dialysis treatments.
 

• The government’s focus on strengthening healthcare infrastructure, expanding dialysis centers, and improving access to renal care is further boosting market growth. Technological advancements in catheter design, including infection-resistant and biocompatible materials, are enhancing treatment safety and efficiency, driving adoption among healthcare providers.
   
• Moreover, rising healthcare awareness and improving insurance coverage are enabling more patients to undergo regular hemodialysis, increasing demand for catheters.
  
   

Latin American Hemodialysis Catheters Market
 

Brazil leads the Latin American market, exhibiting remarkable growth during the analysis period, due to a high prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD) in the country, driven by increasing cases of diabetes, hypertension, and obesity. The growing geriatric population further contributes to the rising demand for hemodialysis treatments, as older patients are more susceptible to renal complications.
 

• Government initiatives aimed at improving access to renal care, along with investments in healthcare infrastructure and expansion of dialysis centers, have enhanced treatment availability across urban and semi-urban regions. Additionally, rising awareness about kidney health, early diagnosis, and patient education programs support the adoption of hemodialysis catheters.
   
• Brazil also benefits from the presence of established medical device manufacturers and distributors, ensuring consistent supply and technological advancements, such as infection-resistant and long-term catheters.
  
   

Middle East and Africa Hemodialysis Catheters Market
 

Saudi Arabia market to experience substantial growth in the Middle East and Africa hemodialysis catheters in 2024, because chronic kidney disease (CKD) and end-stage renal disease (ESRD) do increasingly prevail within the region. Diabetes, hypertension, along with obesity rates are increasing within, furthermore they are major risk factors for kidney failure. These rising rates greatly affect the expanding patient group.
 

• Government initiatives to enhance healthcare infrastructure, expand dialysis centers, and improve access to renal replacement therapies are further boosting market growth. Additionally, high healthcare expenditure, coupled with increasing awareness about kidney health and early diagnosis, is encouraging patients to seek timely hemodialysis treatments.
   
• The adoption of technologically advanced catheters with improved biocompatibility, reduced infection risks, and longer usability is also driving demand. Furthermore, partnerships between medical device manufacturers and healthcare providers are ensuring wider distribution and availability, positioning Saudi Arabia as a key growth region within the Middle East and Africa.
   

Hemodialysis Catheters Market Share

The hemodialysis catheters industry is shaped by a mix of established global leaders and emerging innovators, creating a dynamic and moderately consolidated competitive landscape. Key players such as Becton, Dickinson and Company, Baxter International, AngioDynamics, Medtronic, Teleflex, and Vygon collectively account for a significant portion of the market share, estimated at around 47%. The hemodialysis catheters market is shaped by a mix of established global leaders and emerging innovators, creating a dynamic and moderately consolidated competitive landscape. Market competition is largely driven by continuous product innovation, strategic partnerships, and mergers and acquisitions aimed at expanding geographic reach and enhancing product portfolios.
 

Companies are increasingly focusing on developing advanced catheters with improved biocompatibility, anti-microbial coatings, and designs that minimize infection and thrombosis risks, catering to the rising demand for safer and more efficient hemodialysis solutions. Regional expansion into emerging markets, where the prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD) is rising, has become a critical growth strategy. Additionally, investments in research and development, coupled with efforts to comply with stringent regulatory standards, are intensifying market rivalry.
 

Competitive pricing, distribution network optimization, and collaborations with healthcare providers are further influencing market dynamics. Overall, the combination of technological advancements, strategic initiatives, and growing global demand is driving a highly competitive environment while promoting innovation and improved patient outcomes in the market.
 

Hemodialysis Catheters Market Companies

Prominent players operating in the hemodialysis catheters are as mentioned below:

• Amecath
• AngioDynamics
• B. Braun
• Bain Medical Equipment
• Baxter
• Becton, Dickinson and Company (BD)
• Cook Medical
• Delta Med
• Healthline Medical Products
• Medcomp
• Merit Medical
• Mozarc Medical
• Polymed
• ST Stone Medical
• Teleflex
• Vygon

• Becton, Dickinson and Company (BD) leads the hemodialysis catheters market with a share of 13.9% in 2024. BD is renowned for its innovative vascular access solutions, offering high-quality hemodialysis catheters with advanced designs that reduce infection and thrombosis risks. The company emphasizes safety, reliability, and ease of use, supported by extensive clinical validation and a global distribution network that ensures accessibility in key markets.
   
• Baxter International focuses on comprehensive renal care solutions, providing durable and efficient hemodialysis catheters. Its USPs include patient-centric designs, biocompatible materials, and integrated dialysis systems that enhance treatment efficacy. Strong global presence, robust research and development capabilities, and commitment to improving patient outcomes further distinguish Baxter in the hemodialysis catheter market.
   
• B. Braun strength lies in its comprehensive portfolio of hemodialysis catheters focused on safety, durability, and infection prevention. The company leverages decades of clinical expertise, advanced material technologies, and strong global distribution to deliver reliable vascular access solutions. With an emphasis on patient comfort, reduced complication rates, and sustainable manufacturing practices, B. Braun positions itself as a trusted partner for high-performance, patient-centric dialysis care worldwide.
   

Hemodialysis Catheters Industry News

• In July 2022, B. Braun Medical Inc., a leading manufacturer in infusion therapy, announced the launch of its new Introcan Safety 2 IV Catheter, featuring one-time blood control. This innovation enhances IV access safety for physicians by reducing the risk of blood exposure and needlestick injuries.
   
• In April 2021, the Pristine Long-Term Hemodialysis Catheter, developed by Pristine Access Technologies, Ltd. (later acquired by Becton, Dickinson and Company), received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The launch of this catheter is expected to expand the company’s product portfolio and strengthen its position within the hemodialysis market.
   

The hemodialysis catheters market research report includes in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 - 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Catheter Type

• Short-term hemodialysis catheters
• Long-term hemodialysis catheters     

Market, By Product

• Tunneled catheters
  • Cuffed tunneled catheters
  • Non-cuffed tunneled catheters
• Non-tunneled catheters

Market, By Material

• Polyurethane
• Silicone

Market, By Tip Configuration

• Step-tip catheters
• Split-tip catheters
• Symmetric catheters
• Other tip configurations

Market, By Lumen

• Single-lumen
• Double-lumen
• Triple-lumen

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea 
• Latin America
  • Brazil
  • Mexico
  • Argentina 
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE